TY  - GEN
AU  - Rossello, Xavier
AU  - Raposeiras-Roubin, Sergio
AU  - Latini, Roberto
AU  - Dominguez-Rodriguez, Alberto
AU  - Barrabés, José A
AU  - Sánchez, Pedro L
AU  - Anguita, Manuel
AU  - Fernández-Vázquez, Felipe
AU  - Pascual-Figal, Domingo A
AU  - De la Torre Hernandez, José M
AU  - Ferraro, Stefano
AU  - Vetrano, Alfredo
AU  - Pérez-Rivera, José A
AU  - Prada-Delgado, Oscar
AU  - Escalera, Noemí
AU  - Staszewsky, Lidia
AU  - Pizarro, Gonzalo
AU  - Agüero, Jaume
AU  - Pocock, Stuart
AU  - Ottani, Filippo
AU  - Fuster, Valentin
AU  - Ibáñez, Borja
PY  - 2022
DO  - 10.1093/ehjcvp/pvab060
UR  - http://hdl.handle.net/20.500.12105/15103
AB  - Aims: There is a lack of evidence regarding the benefits of β-blocker treatment after invasively managed acute myocardial infarction (MI) without reduced left ventricular ejection fraction (LVEF). Methods and results: The tREatment with Beta-blockers...
LA  - eng
PB  - Oxford University Press
KW  - Myocardial Infarction
KW  - Ventricular Dysfunction, Left
KW  - Adrenergic beta-Antagonists
KW  - Humans
KW  - Prospective Studies
KW  - Stroke Volume
KW  - Ventricular Function, Left
TI  - Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
TY  - preprint
ER  -